Catalysts

WHITE PAPERS AND CASE STUDIES

• Innovating The mAb Characterization Process

  Understanding the characteristics of a molecule's "personality" is crucial for optimizing development and manufacturing. Learn how to overcome the challenges in the characterization process.

• Driving Seamless Tech Transfer Of Multiple Projects Within A Short Timeline

  Uncover how we were able to provide seamless technology transfers and uninterrupted production to deliver critical therapies efficiently and reliably to patients.

• Groundwater DWTP (NJ) – DEXSORB Full-Scale

  Cyclopure was invited to replace ion exchange resin to remove PFAS from groundwater at a groundwater pump station, located in New Jersey. The decision to replace IXR was due to poor PFAS removal caused by manganese fouling.

• Expand Bandwidth With A Trusted Regulatory Writing Partner

  Find out how a mid-size biotech lacking the bandwidth, expertise, and resources to independently handle its regulatory writing requirements overcame this challenge.

• Container Selection For A Highly Sensitive Drug Product: A Success Story

  Learn about the importance of selecting the right container for sensitive drug products and how close collaboration is crucial for avoiding commercialization delays and safety risks to patients.

• Innovative Water Reuse Solutions With Xylem's Advanced Treatment Technology

  Transitioning to advanced purification methods like UV-hypochlorite oxidation allows municipalities to secure reliable, local water supplies. These strategies mitigate drought risks and protect coastal environments by transforming wastewater into a high-quality resource for reuse.

• Time-To-Manufacture Reduced By 30% Through Rapid Transfer Strategy

  Critical formulation deficiencies were solved through rapid batch manufacturing and process adjustments. This enabled a 30% reduction in time-to-manufacture and prevented delays to the start date.

• Driving A High-Adherence LTFU Trial Without An EDC

  Discover how our partnership with a client was able to deliver a ten-year long-term follow-up (LTFU) trial that delivered an over 90% adherence rate while keeping trial costs low by not using an EDC.

• Vaccine Trial Sees >90% eCOA Adherence

  Discover how we addressed vaccine trial challenges and drove remarkable success, achieving over 90% adherence to eCOA, ensuring active engagement from the trial participants, and yielding consistent, reliable trial data.

• Case Study: Global Oncology

  Scout's transportation, expense reimbursement, and time and wage loss compensation helped an oncology study recruit and retain hard-to-reach patients.

• PFAS Removal System Proven Effective In Removing Both Long And Short Chain PFAS

  A new system removed all nine PFAS compounds from a municipality's water to non-detect levels in a single pass. Unlike traditional methods, it addresses both long- and short-chain PFAS while generating minimal waste.

• Biostatistics And Programming — More Than Just Clinical Trials

  See how our biostatisticians and programmers successfully ingested, cleaned, and analyzed the data, ultimately providing a small biotech company with several interesting and actionable measures.